The key objective was to evaluate the efficacy of your vaccine compared to placebo in reducing cocaine use. Secondary targets provided confirming vaccine immunogenicity via IgG anti-cocaine antibody ranges and assessing the protection and tolerability of vaccination by way of a twenty 7 days research and at 24 week stick https://cyrily239smo0.izrablog.com/profile